Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms | MicrobiomeTrials← Back to trialsNCT04541082
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2020-10-26Est. Completion: 2027-03-31
Enrollment target: 102 participants Locations- National Institutes of Health, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Cushing Disease
Background:
The pituitary gland produces hormones. A tumor in this gland can cause it to produce too much of the hormon…
Bethesda, United StatesEst. completion Jan 3, 2040
Fabry Disease
The aim of this randomized controlled study is to evaluate the effects of a six-week low-fermentable oligosaccharides, d…
Istanbul, Turkey (Türkiye)Est. completion Jan 30, 2027
Prostate Neoplasms
Prostate Cancer
Renal Cell Carcinoma
Von Hippel Lindau Disease
This study will evaluate the accuracy and effectiveness of an experimental tracking device for locating abnormalities du…
Bethesda, United StatesCompleted Aug 2, 2028